Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new Locations section appears, listing California, New York, Ohio, and Texas locations, and the page revision is updated to v3.3.3. The former state-specific location subsections have been removed.SummaryDifference0.5%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no study content or user actions are affected.SummaryDifference0.0%

- Check45 days agoChange DetectedThe funding-status disclaimer has been removed from the page. This may affect users’ expectations about whether the trial information is up to date.SummaryDifference0.3%

- Check59 days agoChange DetectedThe updated page shows formatting tweaks and minor layout changes with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedAdded a government operations notice and a version bump to v3.2.0; removed the previous v3.1.0 tag. If any critical content relies on live status, users should review the new notice and links.SummaryDifference4%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.